» Articles » PMID: 36830009

Effects of Microalgae on Metabolic Syndrome

Overview
Date 2023 Feb 25
PMID 36830009
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic syndrome (MetS) is a cluster of metabolic disturbances, including abdominal obesity, hypertension, hypertriglyceridemia, reduced high-density lipoprotein cholesterol (HDL-C) and hyperglycemia. Adopting a healthier lifestyle and multiple drug-based therapies are current ways to manage MetS, but they have limited efficacy, albeit the prevalence of MetS is rising. Microalgae is a part of the human diet and has also been consumed as a health supplement to improve insulin sensitivity, inflammation, and several components of MetS. These therapeutic effects of microalgae are attributed to the bioactive compounds present in them that exhibit antioxidant, anti-inflammatory, anti-obesity, antihypertensive, hepatoprotective and immunomodulatory effects. Therefore, studies investigating the potential of microalgae in alleviating MetS are becoming more popular, but a review on this topic remains scarce. In this review, we discuss the effects of microalgae, specifically on MetS, by reviewing the evidence from scientific literature covering in vitro and in vivo studies. In addition, we also discuss the underlying mechanisms that modulate the effects of microalgae on MetS, and the limitations and future perspectives of developing microalgae as a health supplement for MetS. Microalgae supplementation is becoming a viable approach in alleviating metabolic disturbances and as a unique addition to the management of MetS.

Citing Articles

Influence of Type 2 Diabetes and Adipose Tissue Dysfunction on Breast Cancer and Potential Benefits from Nutraceuticals Inducible in Microalgae.

Sergi D, Melloni M, Passaro A, Neri L Nutrients. 2024; 16(19).

PMID: 39408212 PMC: 11478231. DOI: 10.3390/nu16193243.


Improving Undernutrition with Microalgae.

Panchal S, Heimann K, Brown L Nutrients. 2024; 16(18).

PMID: 39339823 PMC: 11435262. DOI: 10.3390/nu16183223.


Natural products for managing metabolic syndrome: a scoping review.

Abdulghani M, Al-Fayyadh S Front Pharmacol. 2024; 15:1366946.

PMID: 38746011 PMC: 11091304. DOI: 10.3389/fphar.2024.1366946.


Algae-Derived Natural Products in Diabetes and Its Complications-Current Advances and Future Prospects.

Pereira L, Valado A Life (Basel). 2023; 13(9).

PMID: 37763235 PMC: 10533039. DOI: 10.3390/life13091831.


Anti-Adipogenic Activity of and Its Secondary Metabolites.

Todorova V, Savova M, Ivanova S, Ivanov K, Georgiev M Nutrients. 2023; 15(13).

PMID: 37447387 PMC: 10346812. DOI: 10.3390/nu15133061.


References
1.
Dvir I, Stark A, Chayoth R, Madar Z, Arad S . Hypocholesterolemic effects of nutraceuticals produced from the red microalga Porphyridium sp in rats. Nutrients. 2012; 1(2):156-67. PMC: 3257595. DOI: 10.3390/nu1020156. View

2.
Brown J, Plutzky J . Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation. 2007; 115(4):518-33. DOI: 10.1161/CIRCULATIONAHA.104.475673. View

3.
Lasker S, Rahman M, Parvez F, Zamila M, Miah P, Nahar K . High-fat diet-induced metabolic syndrome and oxidative stress in obese rats are ameliorated by yogurt supplementation. Sci Rep. 2019; 9(1):20026. PMC: 6934669. DOI: 10.1038/s41598-019-56538-0. View

4.
Padanad M, Konstantinidou G, Venkateswaran N, Melegari M, Rindhe S, Mitsche M . Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis. Cell Rep. 2016; 16(6):1614-1628. PMC: 4981512. DOI: 10.1016/j.celrep.2016.07.009. View

5.
Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17):2735-52. DOI: 10.1161/CIRCULATIONAHA.105.169404. View